Consistent with the aforementioned in vivo experiment, CaM showed a decreasing trend after TFP treatment ( Figures 4 C and 4D).
← all excerpts
Trifluoperazine regulates blood-brain barrier permeability via the MLCK/p-MLC pathway to promote ischemic stroke recovery.
1
—
—